Fourth addendum to ACMD’s report on synthetic cannabinoids

Document type
Guidance note
Publisher
Advisory Council on the Misuse of Drugs
Date of publication
16 November 2016
Subject(s)
Substance Misuse
Collection
Social welfare
Material type
Reports

Download (90KB )

This addendum recommends revisions to the regulations regarding the scheduling of synthetic cannabinoids. Specifically, they recommend the addition of paragraphs to the Misuse of Drugs Regulations 2001 and the Misuse of Drugs (Designation) Order 2015. The Advisory Council on the Misuse of Drugs (ACMD) have previously provided advice to the minister on the ‘third generation’ of synthetic cannabinoids, through the initial report of 27 November 2014 and the subsequent addenda of 25 March 2015, 14 January 2016 and 15 July 2016. The ACMD have recommended these substances are controlled as Class B drugs under the Misuse of Drugs Act 1971, in line with their previous advice on the first and second generations of these synthetic cannabinoids, as it is their opinion that the harms are commensurate.  As the substances captured by this advice have no known medicinal use, it is appropriate that these substances are controlled in Schedule 1 of the Regulations.

Related to Substance Misuse

Drug misuse and dependence: UK guidelines on clinical management

Downloadable guidelines on treating people with drug misuse and drug dependence problems

Family drug and alcohol court national unit: independent evaluation: research report

The family drug and alcohol court (FDAC) offers an alternative form of care proceedings for children put at risk of significant…

Temporary class drug order on methiopropamine.

This policy briefing recommends that the TCDO for methiopropamine (MPA) is remade for up to a further 12-month period at…

More items related to this subject